Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. - Wikidata - awgldk - TriplyDB

Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.

Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.

http://www.wikidata.org/entity/Q35588327

about

Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor.Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors Role of hypoxia-inducible factors in breast cancer metastasis The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma.Implications of Hypoxia in Breast Cancer Metastasis to Bone Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha.Natural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).Fluorescent stains for quantification of DNA by confocal laser scanning microscopy in 3-D.A compact VEGF signature associated with distant metastases and poor outcomes.Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features 1α, 25-Dihydroxyvitamin D regulates hypoxia-inducible factor-1α in untransformed and Harvey-ras transfected breast epithelial cells Hypoxia induces differential translation of enolase/MBP-1.Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4 Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management Clinical biomarkers for hypoxia targeting Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells.Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells.Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes.SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors.The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.Impact of preoperative anemia on relapse and survival in breast cancer patients.HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer The potential of hypoxia markers as target for breast molecular imaging--a systematic review and meta-analysis of human marker expression.UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α.Differential hypoxic regulation of hypoxia-inducible factors 1alpha and 2alpha.Nontranscriptional role of Hif-1α in activation of γ-secretase and notch signaling in breast cancer.Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype.Expression of hypoxic markers and their prognostic significance in soft tissue sarcoma Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer Expression of Hypoxia-inducible factor 1-α and vascular endothelial growth factor-C in locally advanced breast cancer patients.LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer

P2860

Q24813750-57E3132F-1520-4E9C-BD31-F7A6252E94F9 Q24815236-6E6522B4-E125-4075-8187-E6F1B97C1902 Q25255387-90578415-33F3-414B-B882-745D7A60A816 Q26823482-1D456831-2423-4558-8CE9-91586CB8FBFA Q26860122-878322D3-BDF6-4F71-B6E4-380F15B7C85A Q27852466-A1091F0B-C70C-41F2-83FE-1E2B17933959 Q28077444-6AB861B2-A5D4-426C-B15A-38B425A69D53 Q28535362-55664764-F8D0-4934-A0A4-681BA8877FAD Q29615944-7C13E2A1-A871-41CA-B9CE-0FF7C638882E Q33234082-6CE70DCE-B575-4ECC-8989-0D146EA7EF98 Q33235403-CDAD1EB4-8983-4A79-A8C9-E25F51CC1DF0 Q33345382-D315541B-92FD-4A00-8FAC-C6D0553B380B Q33418745-9322F61C-CA0A-4F70-85A8-2E87106865AB Q33463900-E358A529-4388-4776-A82D-C304AA06035E Q33556370-66F58AE1-D3BF-42EE-8BE7-0401373123D1 Q33562305-6BE4B429-1111-482D-B198-C835D77090CE Q33584212-7735B158-6DB5-48F7-B634-C490305B9EBE Q33588105-AB1934C0-1FE7-4491-BF29-25CAA990B508 Q33611310-476E590D-2569-4D98-ADD1-D602980B70CC Q33652379-E0E1CF8B-B25C-4DC3-8AA4-59BEE20116B7 Q33714638-4F585BB0-0E60-4833-B9AB-9879BB45E1A7 Q33750192-CBE18A76-5B82-4993-A97E-208840DF7359 Q33826009-438BD582-32E4-4D7F-8890-626DC49376C2 Q33856008-B294ED8F-D048-4841-AD06-8F7A00970A32 Q34017131-DA4C8FD0-2FA6-44F2-B872-0D90A1BF6B2C Q34035225-BA6524B4-8CEE-47F0-86CF-3CF63A9F27F0 Q34288454-7BEE407A-C4BD-4CFC-819D-AC42797FE4EE Q34479984-B41591A9-15B3-467F-8FAF-F1497EBCDA0E Q34565736-D5AB9DE0-5E00-4C81-9119-6D5B0C6BF91A Q34586591-6ED8A5FE-BD4C-426F-8C39-8C64AA1C5DAD Q34733888-4E90BEC4-50B4-45C0-A1F1-5EE725FDE5A6 Q35037251-C6892303-D510-4114-BC0B-33FFBF2C8555 Q35050488-B9501F42-FEB4-47DC-8879-CD138A755F74 Q35053481-6CA4872C-E1AF-4AB3-A54B-6B56013873E1 Q35136674-95D9BCBF-4DE5-4637-95C8-B61D0882235D Q35149689-20CB13B1-B6FA-4ECB-8E37-C8B8A55FE5A6 Q35167655-3C976046-69AE-4A0E-9AFE-5E3474B16917 Q35169825-C63183CC-473D-424E-A19B-DA87ADDE88FA Q35179664-A0D6CBEB-170D-4318-BCAD-EB83E51AF52B Q35485542-C562247D-4A45-48F1-B001-DA44EA31EF32

P2860

Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.

http://www.wikidata.org/entity/Q35588327

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Differential prognostic impact ...... ion in invasive breast cancer.

@ast

Differential prognostic impact ...... ion in invasive breast cancer.

@en

type

label

Differential prognostic impact ...... ion in invasive breast cancer.

@ast

Differential prognostic impact ...... ion in invasive breast cancer.

@en

prefLabel

Differential prognostic impact ...... ion in invasive breast cancer.

@ast

Differential prognostic impact ...... ion in invasive breast cancer.

@en

P1433

Q35588327-265E189A-B799-4A06-A0A5-AFDC770B84B3

P1476

Q35588327-582C6909-3D52-4192-80A3-9B52D53526FA

P2093

Q35588327-0700EB84-9C3F-4ED2-BA16-5537B25451CE

Q35588327-1DB40F78-A206-45BA-B288-06C1FC538BCA

Q35588327-4B323B69-6FB3-4DC9-85AB-8B98B147C29D

Q35588327-6F8C452E-DCD3-436F-97B8-E7354484D308

Q35588327-727E4741-6B05-45D4-AA55-E81CF4326CDB

Q35588327-8B0FD1DE-D195-4C05-8C8E-B1F28A6EE71C

Q35588327-9CAEDBEC-10C8-4DF1-82BA-BD85B2425C5F

Q35588327-9F841E90-C96D-4B7B-9521-38431C55719A

Q35588327-D4B3A9D8-6F06-469E-B456-826E62BE3346

Q35588327-EDEC44F5-9601-41DC-B837-625EC013B0CF

P2860

Q35588327-09A22C25-7287-45DF-8945-9C038E088DC9

Q35588327-0A77B865-DCE2-41AF-95D0-002F4897B7A2

Q35588327-0C3D689B-6DA4-49EA-A9BD-B92C921E1F71

Q35588327-0D16FE4E-F735-4E67-B69B-8DC272F5D1CA

Q35588327-0EE1DBCD-4052-40AD-8F9D-0DE7BB596429

Q35588327-15A286FD-E607-4BC7-9D95-173EE4FAF16E

Q35588327-160B528B-5A70-4235-883D-984D19BE3AC0

Q35588327-1796F7E6-9F5D-4BCC-856E-D99A182C4BF1

Q35588327-2040DFBC-B08E-4019-94EB-1092867B5061

Q35588327-2FB0FEDC-741A-4F01-978E-E3DC3D128DB1

P304

Q35588327-BC2C9D41-B7A5-4096-B0A2-7D56C9ED7758

P31

Q35588327-2F079E4F-21BD-4DC5-A4A9-5B3E8DE7B8A0

P356

Q35588327-9F7D7079-E666-4455-8E99-2C416D06A03E

P407

Q35588327-692FDCE2-0BC4-4232-8244-86DDAEF89DC1

P433

Q35588327-0131DD89-6AA3-4E7A-A18F-41B8358679FB

P478

Q35588327-AE559C30-3A67-437E-83F4-8ECF6ECB7092

P577

Q35588327-EB8A535B-0270-44D9-BD23-CA499A9D3CE4

P5875

Q35588327-84A18B40-B767-41D7-BAA4-E7475AA5E999

P698

Q35588327-F4CC37D5-51C3-47E5-945A-5DBD99CBC683

P921

Q35588327-F5D6B5BC-6852-44F1-AC9E-85F5FF5C8B74

P932

Q35588327-FD93E95E-1406-4BA1-BDD2-1185D001803C

P356

JCP.2004.019885

P1433

Journal of Clinical Pathology

P1476

Differential prognostic impact ...... ion in invasive breast cancer.

@en

P2093

A E Greijer

http://www.w3.org/2001/XMLSchema#string

A L Harris

http://www.w3.org/2001/XMLSchema#string

A Shvarts

http://www.w3.org/2001/XMLSchema#string

E van der Wall

http://www.w3.org/2001/XMLSchema#string

H van Tinteren

http://www.w3.org/2001/XMLSchema#string

M M Vleugel

http://www.w3.org/2001/XMLSchema#string

M van Berkel

http://www.w3.org/2001/XMLSchema#string

P J van Diest

http://www.w3.org/2001/XMLSchema#string

P van der Groep

http://www.w3.org/2001/XMLSchema#string

Y Aarbodem

http://www.w3.org/2001/XMLSchema#string

P2860

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

Targeting HIF-1 for cancer therapy

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

A novel quasi-viral agent, MaTu, is a two-component system

P304

172-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCP.2004.019885

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8053657

http://www.w3.org/2001/XMLSchema#string

P698

15677538

http://www.w3.org/2001/XMLSchema#string

P921

P932

1770566

http://www.w3.org/2001/XMLSchema#string